ARROWHEAD PHARMACEUTICALS IN's ticker is ARWR and the CUSIP is 04280A100. A total of 278 filers reported holding ARROWHEAD PHARMACEUTICALS IN in Q2 2022. The put-call ratio across all filers is 0.90 and the average weighting 0.3%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2022 | $346,000 | -6.0% | 10,458 | 0.0% | 0.03% | 0.0% |
| Q2 2022 | $368,000 | -23.5% | 10,458 | +0.1% | 0.03% | -10.8% |
| Q1 2022 | $481,000 | -27.9% | 10,450 | +3.9% | 0.04% | -22.9% |
| Q4 2021 | $667,000 | +3.1% | 10,053 | -3.0% | 0.05% | -4.0% |
| Q3 2021 | $647,000 | -24.7% | 10,365 | -0.0% | 0.05% | -23.1% |
| Q2 2021 | $859,000 | +25.0% | 10,368 | +0.0% | 0.06% | +12.1% |
| Q1 2021 | $687,000 | -10.9% | 10,365 | +3.1% | 0.06% | -14.7% |
| Q4 2020 | $771,000 | +78.1% | 10,050 | 0.0% | 0.07% | +65.9% |
| Q3 2020 | $433,000 | -0.2% | 10,050 | 0.0% | 0.04% | -8.9% |
| Q2 2020 | $434,000 | +50.7% | 10,050 | +0.5% | 0.04% | +25.0% |
| Q1 2020 | $288,000 | -54.6% | 10,000 | 0.0% | 0.04% | -41.9% |
| Q4 2019 | $634,000 | +124.8% | 10,000 | 0.0% | 0.06% | +121.4% |
| Q3 2019 | $282,000 | +6.4% | 10,000 | 0.0% | 0.03% | +3.7% |
| Q2 2019 | $265,000 | +44.0% | 10,000 | 0.0% | 0.03% | +35.0% |
| Q1 2019 | $184,000 | +48.4% | 10,000 | 0.0% | 0.02% | 0.0% |
| Q4 2018 | $124,000 | – | 10,000 | – | 0.02% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Western Financial Corp/CA | 820,320 | $33,272,179 | 21.56% |
| Aquilo Capital Management, LLC | 1,103,515 | $44,758,568 | 16.81% |
| M28 Capital Management LP | 143,900 | $5,836,584 | 5.56% |
| WEALTH EFFECTS LLC | 155,620 | $6,311,951 | 3.60% |
| Evolutionary Tree Capital Management, LLC | 92,095 | $3,735,373 | 3.59% |
| Privium Fund Management B.V. | 221,015 | $8,867,122 | 3.36% |
| JOHNSON & JOHNSON | 247,598 | $10,043 | 2.92% |
| COMMODORE CAPITAL LP | 462,111 | $18,743 | 2.82% |
| Avidity Partners Management LP | 1,375,000 | $55,770,000 | 1.21% |
| Capital Impact Advisors, LLC | 26,853 | $1,089,158 | 1.06% |